Joint cartilage has an extremely limited ability to heal itself, which makes “rebuilding” it one of the hardest problems in orthopedic medicine. The tissue lacks its own blood supply and contains very few cells, so the body’s usual repair machinery barely reaches it. That said, researchers have made genuine progress on several fronts: surgical techniques that coax new cartilage-like tissue into damaged areas, injectable therapies that slow breakdown, an experimental drug that has actually thickened cartilage on MRI scans, and early-stage work in gene therapy and 3D bioprinting that could change the field within a decade or two. None of these approaches perfectly restores the original tissue, and some widely marketed options have surprisingly thin evidence behind them.
Why Cartilage Barely Heals on Its Own
Articular cartilage, the smooth white tissue capping the ends of bones inside a joint, is built to absorb shock and reduce friction. It does this remarkably well for decades, but it pays a price in repairability. The tissue has no blood vessels, no nerves, and very few cells relative to its volume. Instead of receiving nutrients through a blood supply, it depends on synovial fluid, the lubricating liquid inside the joint capsule, slowly diffusing in and out during movement.1PubMed Central. The basic science of articular cartilage: structure, composition, and function This design makes cartilage resilient under compression, but it also means that when damage occurs, the usual healing cascade of inflammation, blood clot formation, and cell migration simply does not happen in any meaningful way. A skin cut recruits a swarm of repair cells within hours. A cartilage defect can sit unchanged for years.
Compounding the problem is the tissue’s internal structure. Cartilage is organized into distinct layers with collagen fibers oriented in different directions. Even when new tissue does form in a damaged area, it tends to be fibrocartilage, a tougher, less slippery substitute that wears down faster than the original. This is the central frustration of cartilage repair: getting any new tissue to fill a defect is hard enough, and getting that tissue to match the mechanical properties of native cartilage is harder still.
Surgical Options Available Now
When cartilage damage is localized and the rest of the joint is relatively healthy, surgery offers the most direct path to filling a defect. Three main techniques dominate the field, each with different trade-offs.
Microfracture
Microfracture is the simplest and most widely used approach. A surgeon pokes small holes through the damaged cartilage into the underlying bone, which releases blood and marrow cells into the defect. Those cells form a clot that eventually matures into repair tissue. The catch is that this tissue is mostly fibrocartilage, not the hyaline cartilage the joint originally had. A systematic review of microfracture in athletes found that outcomes depended heavily on patient age, how long symptoms had been present before surgery, the size of the lesion, and what the repair tissue actually looked like on follow-up.2Cartilage. Clinical Outcome and Return to Competition after Microfracture in the Athlete’s Knee: An Evidence-Based Systematic Review Younger patients with smaller defects tended to do best. Over time, the fibrocartilage fill can deteriorate, which is why microfracture is sometimes considered a shorter-term solution or a bridge to a more definitive procedure.
Autologous Chondrocyte Implantation
Matrix-induced autologous chondrocyte implantation, or MACI, takes a more biologically ambitious approach. In a first procedure, a surgeon harvests a small sample of the patient’s own healthy cartilage cells. Those cells are grown in a lab, seeded onto a scaffold membrane, and then implanted into the defect during a second surgery. The goal is to produce tissue that more closely resembles native hyaline cartilage. A systematic review of studies following patients for at least ten years found durable improvements in patient-reported outcomes, and MRI scans showed satisfactory defect fill with an intact graft in most cases.3PubMed Central. Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee: A Systematic Review A separate long-term study confirmed consistently good clinical results at ten years, with low revision rates and high patient satisfaction.4PubMed Central. Factors Influencing Long-term Outcomes After Matrix-Induced Autologous Chondrocyte Implantation: Long-term Results at 10 Years MACI is typically reserved for larger defects and younger, active patients because of the two-surgery commitment and cost.
Osteochondral Autograft Transfer
Sometimes called OATS, this technique involves harvesting a small plug of healthy cartilage and bone from a low-weight-bearing area of the same knee and transplanting it into the defect. Because the plug includes the underlying bone, it can integrate well and provides true hyaline cartilage on the surface from day one. Published evidence shows improved function, pain relief, and good patient satisfaction at early-to-mid-term follow-up.5PubMed Central. Osteochondral Autograft Transfer Procedure: Arthroscopic Technique and Technical Pearls The limitation is size: OATS works best for smaller defects, roughly the diameter of a pencil eraser up to about two centimeters, because you can only harvest so much tissue from a donor site without creating a new problem.
What Injections Can and Cannot Do
Injections are appealing because they are far less invasive than surgery. Three categories get the most attention: platelet-rich plasma, hyaluronic acid, and stem cell-derived therapies. Their ability to reduce pain is better established than their ability to rebuild cartilage.
Platelet-rich plasma (PRP) is made by spinning a sample of your own blood to concentrate the platelets and growth factors. There is evidence that PRP reduces inflammatory signaling in the joint and may slow enzymatic breakdown of cartilage. Some patients report meaningful pain relief, especially in mild-to-moderate osteoarthritis. But the evidence that PRP actually regenerates cartilage tissue is thin. What it more likely does is improve the environment inside the joint, calming inflammation and protecting the cartilage that remains rather than growing new tissue.
Hyaluronic acid injections work differently. Hyaluronic acid is a natural component of synovial fluid, and injecting more of it aims to restore lubrication and cushioning. A systematic review of its mechanisms found that its most frequently reported action was chondroprotection, meaning it helped shield existing cartilage from further damage. Other reported effects included stimulating the production of cartilage building blocks and reducing inflammation.6BMC Musculoskeletal Disorders. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review Like PRP, hyaluronic acid is more about preservation than regrowth.
Stem cell therapies, particularly those using mesenchymal stem cells (MSCs), generate the most excitement and hype. Early thinking was that injected stem cells would differentiate into new cartilage cells. More recent research suggests the benefit comes less from the cells themselves and more from the signaling molecules they release, particularly tiny vesicles called exosomes that can modulate inflammation and nudge the local environment toward repair.7Seminars in Cell & Developmental Biology. MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment This is an active research frontier, and clinics offering stem cell injections for cartilage repair are far ahead of the evidence supporting their claims. If you’re considering such a treatment, the honest state of affairs is that it remains experimental.
Sprifermin and Experimental Drugs
One of the most noteworthy developments in recent years is sprifermin, a lab-made version of a human growth factor called fibroblast growth factor 18. In a randomized, placebo-controlled trial, injections of sprifermin into arthritic knees produced measurable, dose-dependent increases in cartilage thickness over two years. At the highest dose, cartilage thickness grew by a small but real amount, while the placebo group lost cartilage over the same period.8JAMA. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis Automated MRI analysis confirmed these structural changes across multiple regions of the knee joint.9PubMed. Automated MRI assessment confirms cartilage thickness modification in patients with knee osteoarthritis: post-hoc analysis from a phase II sprifermin study An earlier trial had also shown dose-dependent reductions in cartilage loss.10PubMed. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial
The honest caveat is that these changes, while statistically significant, are small in absolute terms: fractions of a millimeter. It also has not yet been proven that these structural improvements translate into less pain or better function at the level patients would notice in daily life. Sprifermin is still in clinical development, not something your doctor can prescribe today. But it represents a genuine proof of concept that a drug can reverse cartilage thinning in a living human joint, which is more than any other pharmaceutical has convincingly achieved.
Glucosamine, Chondroitin, and Collagen Supplements
If you walk into any pharmacy, you will find shelves of supplements marketed for joint health. The two most popular, glucosamine and chondroitin, have been tested extensively, and the results are underwhelming for cartilage rebuilding. A large network meta-analysis found that the effects of both supplements on joint space narrowing, a proxy for cartilage thickness, were tiny and not clinically meaningful compared to placebo.11PubMed. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis The Glucosamine/Chondroitin Arthritis Intervention Trial, a major U.S. study, found no statistically significant difference in cartilage loss between any supplement group and placebo over two years, though the study noted its own limited statistical power.12PubMed Central. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial
Some people report feeling less joint pain while taking these supplements, and it is possible that a modest anti-inflammatory effect exists for certain individuals. But the idea that glucosamine or chondroitin will rebuild or measurably protect cartilage is not well supported by large trials.
Collagen hydrolysate, often sold as collagen peptides, is a newer entrant to the supplement aisle. Lab studies suggest that ingested collagen fragments can reach joint tissue and stimulate cartilage cells to produce more of the structural proteins they need.13PubMed. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature A review of the available evidence noted that hydrolyzed collagen may contain biologically active peptides capable of exerting chondroprotective effects.14PubMed Central. Collagen Supplementation for Joint Health: The Link between Composition and Scientific Knowledge The data here is more encouraging than for glucosamine, but still preliminary. We do not yet have large, definitive trials confirming that collagen supplements meaningfully slow cartilage loss in humans over time.
How Movement Shapes Cartilage Health
Exercise is arguably the best-supported and most underrated tool for maintaining cartilage. Because cartilage has no blood supply, it relies on the pumping action of joint compression and decompression to cycle synovial fluid through its matrix, delivering nutrients and clearing waste. Lab studies have shown that cyclic, rhythmic loading of cartilage tissue can boost protein production by the cells inside it by as much as half compared to unloaded tissue. Constant static pressure, by contrast, suppresses cell activity.15PubMed. Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins In plain terms: moving your joints rhythmically feeds your cartilage; sitting still starves it.
Running, often assumed to be hard on joints, has more nuanced evidence behind it than most people expect. A systematic review and meta-analysis found that changes to lower-limb cartilage after a bout of running are transient and reflect normal fluid shifts rather than damage. Cartilage recovers well from individual runs and appears to adapt to repeated exposure. The review found moderate evidence that running does not lead to new cartilage lesions.16PubMed. The Influence of Running on Lower Limb Cartilage: A Systematic Review and Meta-analysis Research on long-term runners has noted that moderate exercise facilitates nourishment of cells within the cartilage matrix by synovial fluid, which can increase cartilage thickness.17PubMed Central. Effects of long-term running on the structure and biochemical composition of knee cartilage in males: a cross-sectional study
This does not mean all exercise is safe for all joints. People with existing large defects, malalignment, or advanced arthritis need to be strategic about loading. But the general population worrying that running or squatting will “wear down” healthy cartilage has the biology backwards. Reasonable, regular loading is one of the few things that demonstrably keeps cartilage in good shape.
The Subchondral Bone Factor
Cartilage does not exist in isolation. Directly beneath it sits subchondral bone, and the two tissues are in constant biochemical communication. In osteoarthritis, destructive changes in the cartilage are paralleled by characteristic changes in the bone underneath, including abnormal remodeling, growth of new blood vessels into regions that are normally avascular, and sprouting of sensory nerve fibers.18PubMed Central. Bone-cartilage crosstalk: a conversation for understanding osteoarthritis 19Bone Research. Subchondral bone microenvironment in osteoarthritis and pain This bone-cartilage crosstalk means that treating cartilage damage without addressing what is happening in the bone may be treating only half the problem. Some researchers believe that the best future therapies will need to target both tissues simultaneously, restoring normal bone remodeling while coaxing cartilage repair from above.
Clearing Senescent Cells
One of the more intriguing directions in cartilage research involves senescent cells, the “zombie cells” that stop dividing but refuse to die. These cells accumulate in aging and damaged joints and pump out a cocktail of inflammatory molecules that degrade surrounding tissue.20PubMed Central. Targeting cellular senescence as a novel treatment for osteoarthritis In mouse studies, clearing these cells from the joint slowed the progression of post-traumatic arthritis and shifted the local environment toward one that favored cartilage repair. When senescent cells were removed from human osteoarthritic cartilage cells in the lab, inflammatory markers dropped and the expression of cartilage structural proteins increased.21Nature Medicine. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment
Drugs that selectively kill senescent cells are called senolytics. Agents like dasatinib, originally developed as a cancer drug, have shown efficacy in preclinical arthritis models.22Clinical Immunology Communications. Senescence associated osteoarthritis: Emerging therapeutics and future directions The concept is appealing because rather than trying to force cartilage to grow, you remove one of the key biological brakes on its natural maintenance. Human joint trials are still in early stages, but the animal data has been strong enough to generate real momentum in the field.
Gene Therapy and 3D Bioprinting
Further out on the horizon, gene therapy aims to turn the patient’s own joint cells into tiny drug factories. The idea is to deliver genetic instructions that cause cells inside the joint to produce growth factors or anti-inflammatory proteins on a sustained basis, rather than relying on repeated injections. Adeno-associated virus (AAV) has attracted particular interest because, unlike other viral delivery vehicles, it can penetrate deep into cartilage tissue and reach the chondrocytes living inside it.23PubMed Central. The Role of Gene Therapy in Cartilage Repair In one animal study, human stem cells engineered with AAV to produce a cartilage-promoting growth factor were implanted into bone-cartilage defects in rats. Compared to controls, the treated defects showed significantly improved cartilage repair at twelve weeks.24Gene Therapy. Adeno-associated viral gene transfer of transforming growth factor-β1 to human mesenchymal stem cells improves cartilage repair
3D bioprinting takes a different tack. Researchers are developing bioinks, printable hydrogel materials loaded with living cells, that can be deposited layer by layer to match the architecture of a cartilage defect. The appeal of bioprinting is its precision: you can control the internal geometry, stiffness gradients, and cell distribution of a scaffold in ways that traditional surgery cannot.25PubMed Central. Advanced 3D-Printing Bioinks for Articular Cartilage Repair Both gene therapy and bioprinting remain in preclinical or very early clinical stages. They are years away from routine use, but they represent fundamentally different strategies than anything currently available.
How Imaging Is Changing the Timeline
One underappreciated barrier to cartilage repair has been detecting damage early enough to do something about it. Standard X-rays only show cartilage indirectly, by measuring the gap between bones. By the time that gap visibly narrows, significant cartilage has already been lost. Conventional MRI is better but still most useful for identifying structural damage that has already occurred, like cracks or missing chunks.26PubMed Central. Quantitative MRI techniques of cartilage composition
Newer quantitative MRI techniques, including T2 mapping and sodium MRI, can detect biochemical changes in cartilage composition before any visible structural damage has occurred.27PubMed Central. Insights of cartilage imaging in cartilage regeneration These methods can pick up early losses of water content and proteoglycan density, essentially catching cartilage while it is still weakening rather than after it has broken down. As these tools become more widely available, they could shift the treatment window significantly earlier, and earlier intervention almost always means better outcomes. These imaging tools are also valuable for evaluating whether a given treatment is actually working, making them essential infrastructure for the clinical trials testing all the approaches described above.
Mammals That Actually Regenerate
If rebuilding cartilage sounds impossibly difficult, it is worth noting that some mammals do regenerate complex tissues with apparent ease. Spiny mice, small rodents found in Africa and the Middle East, can regrow full-thickness skin after injury, complete with hair follicles, sebaceous glands, and the tiny muscles that make hair stand up.28Development. Model systems for regeneration: the spiny mouse, Acomys cahirinus They accomplish this without the scarring that defines wound healing in nearly every other mammal. Researchers studying these animals hope to identify the molecular switches that allow regeneration rather than fibrosis, with the long-term goal of finding ways to flip those switches in human tissues. Understanding why certain mammals can rebuild what we cannot remains one of the more creative avenues of regenerative medicine, even if practical applications for human cartilage are still speculative.